---
title: Endpoint Surrogacy in First-Line Chronic Lymphocytic Leukemia
date: '2024-08-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39213466/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240831181359&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Patient-level correlation was confirmed in the setting of
  targeted therapies while treatment-effect correlation between PFS and OS remains
  uncertain. MRD response status showed a high treatment-effect correlation with PFS
  but not OS, with the caveat of a limited number of randomized trials with available
  MRD ...'
disable_comments: true
---
CONCLUSION: Patient-level correlation was confirmed in the setting of targeted therapies while treatment-effect correlation between PFS and OS remains uncertain. MRD response status showed a high treatment-effect correlation with PFS but not OS, with the caveat of a limited number of randomized trials with available MRD ...